Wells Fargo & Company »

Hcw Biologics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Hcw Biologics (HCWB) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Hcw Biologics

Tip: Access up to 7 years of quarterly data

All positions including Hcw Biologics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hcw Biologics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3k 1.7k 3.70
2025-06-30 $6.7k 1.7k 3.97

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Hcw Biologics

DRW Holdings
Vanguard Group
Geode Capital Management
Golden State Wealth Management
Wells Fargo & Company
Tower Research Capital
Advisor Group Holdings
SBI Securities

View all funds holding Hcw Biologics